patientMpower: Supporting care transformation for Interstitial Lung Disease across multiple NHS centres

Last month, patientMpower, an alumnus of the DigitalHealth.London Accelerator, was recognised as the SME generating the greatest NHS benefit at the annual showcase event. Here their CEO, Eamonn Costello, summarises the latest digital transformation projects they have been involved in, across outpatient respiratory care pathways at a number of NHS sites.

At patientMpower, we were delighted to have been part of the 2020-2021 cohort of the DigitalHealth.London Accelerator programme, which provided us with multiple opportunities to network and learn from other health and care innovators. Our 1-1 sessions with experts bolstered our evidence generation strategy, built our knowledge of NHS funding and commissioning, NHS priorities in digital transformation and much more.

We are now transforming the way care is delivered for multiple outpatient respiratory services across multiple NHS sites:

In Imperial College Healthcare and Nottingham University Hospital NHS Trusts, an Innovate UK funded programme will evaluate a novel digitally enabled clinical care pathway for patients with Interstitial Lung Disease using patientMpower’s virtual care platform. This project will evaluate the health economic impact of remote monitoring and virtual outpatient care compared to a control.

Over in Guy’s and St Thomas’ NHS Foundation and Royal Devon & Exeter NHS Trust patientMpower will help deliver a NHSX Digital Health Partnership funded project to improve access to specialist respiratory services for patients with this complex lung condition.

Both projects will utilise telemedicine together with patientMpower’s remote monitoring platform to enable data-driven virtual care, with increased frequency of monitoring and improved patient self-management.

Explaining the rationale for the programme running in Imperial College Healthcare NHS Trust Dr Mel Wickremasinghe, Respiratory Consultant, said: ”Interstitial Lung Disease (ILD) is a complex and often rapidly progressing condition which requires close monitoring. Many clinicians turned to remote monitoring as an alternative to clinic spirometry during the pandemic. We are now realising just how valuable this approach is in optimising care of ILD patients, giving us the potential to identify complications earlier whilst also reducing pressure on our service. Collecting outcomes data on this approach is crucial to inform the longer term transformation of care, and as a specialist provider of virtual care solutions for ILD, patientMpower was an obvious choice of partner for this project”.

To find out more about patientMpower, get in touch or visit their website.

DigitalHealth.London is delighted to publish blogs by the NHS staff and digital health companies we support through our programmes, as well as sector thought-leaders, experts and academics. Any opinions expressed within blogs published on our website are those of the author and not necessarily held by DigitalHealth.London. For more information, or if you would like to write a blog for our website, please email